Acorda Therapeutics Inc (ACORQ)
OTCMKTS: ACORQ · Delayed Price · USD
0.721
-0.179 (-19.89%)
Apr 30, 2024, 3:54 PM EDT - Market closed

Acorda Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 2003
Cash & Equivalents
30.6244.6865.22102.9105.19294.35307.48158.62159.24183.38
Upgrade
Short-Term Investments
000063.75151.9900200.1125.45
Upgrade
Cash & Cash Equivalents
30.6244.6865.22102.9168.95446.34307.48158.62359.34308.82
Upgrade
Cash Growth
-31.47%-31.50%-36.61%-39.10%-62.15%45.16%93.85%-55.86%16.36%12.62%
Upgrade
Receivables
17.313.871720.1922.0823.4381.452.2431.4732.21
Upgrade
Inventory
16.1612.7518.5528.6825.2229.0137.543.1436.4826.84
Upgrade
Other Current Assets
10.7310.821.3869.57-15.1429.3215.3218.6724.0422.85
Upgrade
Total Current Assets
74.7982.12102.16221.34201.11528.11441.7272.66451.32390.72
Upgrade
Property, Plant & Equipment
6.37.8911.1325.74165.9860.5236.6734.3140.246.09
Upgrade
Goodwill and Intangibles
22.99305.09335.98366.98402.33710.63717.211,023614.49615.77
Upgrade
Other Long-Term Assets
4.440.56.218.6230.30.412.3912.535.2812.48
Upgrade
Total Long-Term Assets
33.73313.48353.31411.35598.61771.56756.271,070659.98674.35
Upgrade
Total Assets
108.53395.6455.47632.68799.721,3001,1981,3421,1111,065
Upgrade
Accounts Payable
13.379.8110.8512.1626.2648.8627.3726.9314.2317.75
Upgrade
Deferred Revenue
0.230.38000032.4641.5150.5789.05
Upgrade
Current Debt
187.731.558.1976.588.350.620.657.021.171.14
Upgrade
Other Current Liabilities
26.4426.2134.9948.5251.7890.7883.4972.4324.626.44
Upgrade
Total Current Liabilities
227.7737.9554.03137.2586.39140.26143.96147.990.59114.38
Upgrade
Long-Term Debt
3.17171.37182.76183.37241.27343.14334.48324.03291.53289.88
Upgrade
Other Long-Term Liabilities
35.5492.6567.5574.1161.25204.29199.55206.19126.15120.54
Upgrade
Total Long-Term Liabilities
38.71264.02250.31257.47402.51547.43534.02530.22417.68410.43
Upgrade
Total Liabilities
266.48301.97304.33394.73488.9687.68677.98678.12508.27524.81
Upgrade
Total Debt
190.9172.92190.94259.95249.61343.76335.12331.05292.7291.03
Upgrade
Debt Growth
10.40%-9.44%-26.55%4.14%-27.39%2.58%1.23%13.10%0.57%6556.61%
Upgrade
Retained Earnings
-1,189.13-936.27-870.36-766.4-666.81-393.84-455.11-243.97-209.35-220.41
Upgrade
Comprehensive Income
1.430.63-1.02-2.8-1.172.816.86-12.9-0.12-0.07
Upgrade
Shareholders' Equity
-157.9693.62151.14237.96310.82611.98519.99664.21603.03540.26
Upgrade
Net Cash / Debt
-160.28-128.24-125.72-157.05-80.67102.58-27.64-172.4466.6417.8
Upgrade
Net Cash / Debt Growth
--------274.47%-93.40%
Upgrade
Net Cash Per Share
-129.05-126.85-236.74-388.56-203.53260.03-72.11-457.19183.3350.20
Upgrade
Working Capital
-152.9844.1748.1384.08114.73387.85297.74124.76360.73276.34
Upgrade
Book Value Per Share
-127.1892.60284.60588.71784.211562.171356.511761.091713.541575.47
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).